Update shared on 20 Dec 2025
Fair value Increased 3.42%Analysts modestly raised their price target for Synchrony Financial to approximately $86 from about $83, citing expectations for resilient revenue growth supported by benign credit trends, improving profit margins, incremental buybacks, and positive signals from recent strategic initiatives and sector tailwinds.
Analyst Commentary
Bullish analysts highlight a constructive backdrop for Synchrony Financial, pointing to improving revenue momentum, stable credit quality, and enhanced capital return as key drivers supporting higher valuation multiples. They increasingly view the company as well positioned to benefit from sector tailwinds in consumer finance while executing on strategic growth initiatives.
At the same time, more cautious voices underscore that the stock's outperformance and evolving competitive dynamics in consumer payments warrant a balanced view on risk and reward, particularly as investors assess how sustainable current credit trends and growth rates will prove in a slower macro environment.
Bullish Takeaways
- Bullish analysts are nudging price targets higher as they gain confidence that revenue growth will reaccelerate with credit remaining benign, supporting both earnings power and a premium to historical valuation ranges.
- Incremental share repurchase capacity and an extended modeling horizon into 2027 are seen as key supports for per share earnings growth, allowing upside even if top line trends are moderate.
- Strategic initiatives, including the unwinding of prior credit tightening actions and new growth partnerships such as the launch at Walmart, are expected to expand the customer base and reinforce Synchrony's competitive positioning.
- Improving sentiment toward consumer finance and regional banking, helped by lower rate expectations and better near term credit performance, is viewed as a sector tailwind that can narrow the valuation discount versus broader financials.
Bearish Takeaways
- Bearish analysts, including JPMorgan, argue that general purpose card issuers offer a more defensive exposure, citing Synchrony's lower placement in the consumer payment hierarchy and higher delinquency rates as reasons for a more neutral stance.
- There is concern that recent share price strength has outpaced underlying estimate revisions, raising the risk of multiple compression if revenue growth or credit trends fall short of elevated expectations.
- Some investors remain cautious on consumer health heading into upcoming quarters, which could pressure growth in new accounts and spending volumes if labor markets soften further.
- The reliance on favorable credit conditions to sustain margin expansion and buyback driven EPS growth leaves limited room for execution missteps or a faster than expected normalization in loss rates.
What's in the News
- Deutsche Bank raised Synchrony Financial's price target to $93 from $91 and reiterated a Buy rating after the Q3 report, highlighting confidence in revenue growth with benign credit trends (Deutsche Bank research note).
- Synchrony extended its partnership with the American Med Spa Association, introducing preferred CareCredit merchant rates for AmSpa members starting January 1, 2026, to lower transaction costs and expand financing access across more than 24,000 cosmetic and dermatology locations (company client announcement).
- Synchrony and Mitsubishi Electric Trane HVAC US renewed their multi year consumer financing alliance effective October 1, 2025, supporting contractors with customizable financing tools as demand grows for smart, energy efficient HVAC systems (company strategic alliance announcement).
- The company launched The Toro Company credit card program for Toro, Exmark, Spartan and Z Turf dealers, offering digital application tools, special financing options and advanced underwriting via Synchrony's PRISM system to support repeat spending and dealer sales (company client announcement).
- From July 1 to September 30, 2025, Synchrony repurchased 12.1 million shares for $861 million, completing a 20.9 million share, $1.36 billion buyback under the program announced April 22, 2025 (company buyback update).
Valuation Changes
- Fair Value Estimate has risen slightly to approximately $85.57 from about $82.74, reflecting a modestly higher intrinsic value assessment.
- Discount Rate has edged down marginally to roughly 8.98 percent from about 9.03 percent, implying a slightly lower required return and modestly higher valuation support.
- Revenue Growth Assumptions have been reduced moderately to around 17.69 percent from about 19.81 percent, signaling a more measured outlook for top line expansion.
- Net Profit Margin has increased meaningfully to approximately 19.04 percent from about 17.97 percent, indicating improved expected profitability and operating leverage.
- Future P/E Multiple has ticked up slightly to roughly 10.69x from about 10.40x, suggesting a modestly higher valuation multiple applied to forward earnings.
Have other thoughts on Synchrony Financial?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.
